ENTITY
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals (GNP IN)

167
Analysis
Health Care • India
Glenmark Pharmaceuticals Ltd., is a pharmaceutical company. The Company develops generic drugs for inflammation, metabolic disorders, and pain.
more
•19 Aug 2020 16:15

Glenmark Pharmaceuticals - Earnings Flash - Q1 FY 2020-21 Results - Lucror Analytics

Glenmark Pharmaceuticals' Q1/20-21 results were better than expected, despite muted revenue growth amid the COVID-19 pandemic. The company...

Logo
305 Views
Share
bearish•Pvr Inox
•08 Aug 2020 22:43

Forensic Accounting | High Risk Companies in India

As promised at Smartkarma Webinar | Accounting and Insider Diagnostics, we have extended our forensic analysis model to India. To learn more about...

Logo
595 Views
Share
•05 Aug 2020 15:54

Asia HY Monthly - LARA And Credit Bias Study (2020 Update) - Lucror Analytics

In this month’s “In-Focus” section, we discuss LARA and Credit Bias developments for companies under our coverage over the past few years,...

Logo
478 Views
Share
bullish•Parkway Pantai Ltd
•03 Aug 2020 00:19

Parkway Pantai: Good Brand with Limited Upside

We initiate our coverage of Parkway Pantai Ltd (0794727D SP) (Parkway Pantai), a wholly-owned subsidiary of IHH Healthcare (IHH MK) of which major...

Logo
528 Views
Share
•30 Jul 2020 08:54

Morning Views Asia: Glenmark Pharmaceuticals, Redco Properties

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region,...

Logo
337 Views
Share
x